PD Dr. med. Manuel Meyer | Prof. Dr. med. Adam Czaplinski | Tel. +41 44 295 30 45
Prof. Dr. med. Adrian M. Siegel | Tel. +41 44 295 30 30
Theaterstrasse 8, 8001 Zürich | www.neurozentrumbellevue.ch
Prof. Dr. med. Adam Czaplinski – Publikationen
Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational study.
Fischer M, Rüegg S, Czaplinski A, Strohmeier M, Lehmann A, Tschan F, Hunziker PR, Marsch SC.
Crit Care. 2010;14(2):R64
Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome.
Sutter R, Mengiardi B, Lyrer P, Czaplinski A.
Neuromuscul Disord. 2009;19(10):709-10.
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
Kuhle J, Lindberg RL, Regeniter A, Mehling M, Steck AJ, Kappos L, Czaplinski A.
Eur J Neurol. 2009;16(6):771-4.
Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.
Steck AJ, Czaplinski A, Renaud S.
Neurotherapeutics. 2008;5(4):528-34.
Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
D'Souza M, Kappos L, Czaplinski A.
J Neurol Sci, 2008;274(1-2):76-9
Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.
Steck AJ, Czaplinski A, Renaud S.
Neurotherapeutics, 2008;5:528-34
ALSFRS and appel ALS scores: Discordance with disease progression.
Voustianiouk A, Seidel G, Panchal J, Czaplinski A, Yen A, Appel SH, Lange DJ.
Muscle Nerve, 2008;37(5):668-72
Isolierte Nervenausfälle, Entrapment syndrome.
Czaplinski A.
In: Internistische Notfälle, 2008. Schoenenberger et al. Thieme Verlag
Nicht-traumatische Querschnittslähmungen.
Czaplinski A.
Info Neurologie Psychiatrie, 2007; 5: 15-19
Cranial and peripheral neuropathy due to leptomeningeal infiltration in patient with Waldenstrom's macroglobulinemia.
R. Sutter, C. Arber, A. Tichelli, AJ. Steck, A. Czaplinski
J Neurology,2007;254:1122-3.
Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome.
A. Becker, M. Hardmeier, AJ. Steck, A. Czaplinski
European J Neurology, 2007;14:e3
Application of the Database Controls in Experimental Trials for ALS.
Czaplinski, LJ. Haverkamp, AA. Yen, EP Simpson, EC. Lai, SH Appel
Neurology, 2006;67:1827-32.
Slower disease progression and prolonged survival in contemporary ALS patients: is the natural history of ALS changing?
A. Czaplinski, AA. Yen, EP. Simpson, SH. Appel
Archives of Neurology, 2006;63:1139-1143
Percent-predicted forced vital capacity (FVC) at first examination is a meaningful indicator of disease progression and survival in an ALS clinic population.
A. Czaplinski, AA. Yen, SH. Appel
Journal of Neurology, Neurosurgery and Psychiatry, 2006;77:390-392
Amyotrophic Lateral Sclerosis: Can We Predict the Course of Disease?
A. Czaplinski, SH. Appel
Swiss Archives of Neurology and Psychiatry;2006;157:317-322
Symptomatische Therapie der Amyotrophischen Lateralsklerose.
A.Czaplinski, K. Schweikert, W.Strobel, AJ. Steck, M. Weber
Schweiz Rundsch Med Prax. 2006;95:263-271
Amyotrophic lateral sclerosis: early predictors of prolonged survival.
A. Czaplinski, AA. Yen, SH. Appel
Journal of Neurology, 2006;253(11):1428-36
Predictability of disease progression in amyotrophic lateral sclerosis.
A. Czaplinski, AA. Yen, EP. Simpson, SH. Appel
Muscle & Nerve, 2006;34:702-8
IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy.
R. Lombardi, B. Erne, G. Lauria, D. Pareyson, M. Borgna, M. Morbin, A. Arnold,
A.Czaplinski, P. Fuhr, N. Schaeren-Wiemers, A.J. Steck
Ann Neurol. 2005; 57:180-7
Immune mediated neuropathies--an update on therapeutic strategies.
A. Czaplinski, A.J. Steck
J Neurol. 2004;251:127-37
Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis.
A. Czaplinski, A.J. Steck, P.M. Andersen, M. Weber
Eur J Neurol. 2004;1:567-8
Einsatz von i.v. Immunoglobulinen in der Neurologie. Evidenzbasierter Konsens.
M.Stangel, R. Gold (A. Czaplinski unter den Mitglieder der IVIg Konsensusgruppe).
Nervenarzt 2004;75:801-815
Ice pack test for Myasthenia gravis. A simple, noninvasive and safe diagnostic method.
Czaplinski, A.J. Steck, P. Fuhr
J Neurol. 2003;250:883-4
Respiratory failure due to bilateral diaphragma palsy as first manifestation of ALS.
A. Czaplinski, W. Strobel, C. Gobbi, A. J. Steck, P. Fuhr, D. Leppert
Med Sci Monit. 2003;9:34-6
Inclusion Body Myositis (IBM). A review.
A. Czaplinski, S. Renaud, P. Fuhr.
Schweiz Rundsch Med Prax. 2003;92:649-54
Actual aspects of myasthenia gravis treatment
A. Czaplinski, A. J. Radziwill, A. J. Steck.
Pol Merk Lek 2003;14:134-140
Diagnostic aspects of botulism. The diagnostic value of repetitive stimulation in the diagnosis of botulism.
A. Czaplinski, A.J. Radziwill, P. Graber, P. Fuhr, A.J. Steck
Akt Neurol 2002;29:76-82
Tic disorders: A review.
A. Czaplinski, A.J. Steck, P. Fuhr
Polish Neurology and Neurosurgery 2002;36:493-504
Antibody testing in peripheral neuropathies - a critical approach
A. Czaplinski, A.J.Steck
Swiss Archives of Neurology and Psychiatry 2002; 153:301-7
Early immunomodulatory treatment of multiple sclerosis.
A. Czaplinski
Polish Neurology and Neurosurgery 2001;3:957-60
Einschlusskörperchenmyositis. Gibt es ein typisches klinisches symptomspektrum?
A. Czaplinski
Info. Neurologie und Psychiatrie 2006; (Rezension)
Neurologie. Masuhr und Neumann. Thieme Verlag.
A. Czaplinski
Swiss Archives of Neurology and Psychiatry 2006; (Rezension)
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Diese Seite drucken